These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657 [TBL] [Abstract][Full Text] [Related]
3. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients. Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Fontanini G Oncol Rep; 2008 Mar; 19(3):771-3. PubMed ID: 18288414 [TBL] [Abstract][Full Text] [Related]
5. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
6. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856 [TBL] [Abstract][Full Text] [Related]
7. Expression of thymosin beta10 and its role in non-small cell lung cancer. Gu Y; Wang C; Wang Y; Qiu X; Wang E Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485 [TBL] [Abstract][Full Text] [Related]
8. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134 [TBL] [Abstract][Full Text] [Related]
10. First clinically useful marker for lung cancer identified. Oncology (Williston Park); 2003 May; 17(5):737-8. PubMed ID: 12800797 [No Abstract] [Full Text] [Related]
11. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival. Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576 [TBL] [Abstract][Full Text] [Related]
12. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. Paleari L; Russo P; Cesario A; Granone P J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241-2. PubMed ID: 18603108 [No Abstract] [Full Text] [Related]
13. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Hsu NY; Cheng YW; Chan IP; Ho HC; Chen CY; Hsu CP; Lin MH; Chou MC Oncol Rep; 2009 Jan; 21(1):81-7. PubMed ID: 19082446 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation in lung cancer. Park IK N Engl J Med; 2008 Jun; 358(23):2513; author reply 2514. PubMed ID: 18536092 [No Abstract] [Full Text] [Related]
17. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival]. Cerón J; Peñalver JC; Jordá C; Padilla J Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270 [TBL] [Abstract][Full Text] [Related]
18. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control. Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636 [TBL] [Abstract][Full Text] [Related]
19. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis. Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Donati V; Fontanini G Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947 [TBL] [Abstract][Full Text] [Related]
20. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]